Pulmonary Valve, Hip Device Under the Microscope in Latest EU Panel Opinions

article image

Two new MDR expert panel opinions were published by the EU this week. It also reposted the first MDR panel opinion that had been placed online and then taken down over the summer. The clinical consultations offer a window into the extra scrutiny that high-risk devices are subject to under the new regulations.

Developers of new high-risk implantable devices or active devices that deliver a medicine now have three EU expert panel consultations to help inform their CE mark clinical evaluation efforts. The European Commission has posted two new Clinical Evaluation Consultation Procedure (CECP) opinions in the past week, and it also reposted one that it previously took offline.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: